These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 859079)

  • 1. Toxoplasmosis in nude mice.
    Lindberg RE; Frenkel JK
    J Parasitol; 1977 Apr; 63(2):219-21. PubMed ID: 859079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental infection of athymic mice with Toxoplasma gondii.
    Buxton D
    J Med Microbiol; 1980 May; 13(2):307-11. PubMed ID: 7381918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of congenitally athymic (nude) mice with Toxoplasma gondii.
    Hof H; Emmerling P; Höhne K; Seeliger HP
    Ann Microbiol (Paris); 1976; 127B(4):503-7. PubMed ID: 1023790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
    Darcy F; Maes P; Gras-Masse H; Auriault C; Bossus M; Deslee D; Godard I; Cesbron MF; Tartar A; Capron A
    J Immunol; 1992 Dec; 149(11):3636-41. PubMed ID: 1431132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
    Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infection of the athymic rat by Toxoplasma gondii].
    Santoro F; Auriault C; Leite P; Darcy F; Capron A
    C R Acad Sci III; 1987; 304(11):297-300. PubMed ID: 3103874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance to an intracellular protozoan (Toxoplasma gondii) by passively administered antibody.
    Araujo FG; Remington JS
    J Immunol; 1974 Nov; 113(5):1424-8. PubMed ID: 4607763
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective role of IgE in immunocompromised rat toxoplasmosis.
    Ridel PR; Auriault C; Darcy F; Pierce RJ; Leite P; Santoro F; Neyrinck JL; Kusnierz JP; Capron A
    J Immunol; 1988 Aug; 141(3):978-83. PubMed ID: 3397537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.
    Araujo FG
    J Immunol; 1992 Nov; 149(9):3003-7. PubMed ID: 1357033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma antigen isolated by affinity chromatography with monoclonal antibody protects mice against lethal infection with Toxoplasma gondii.
    Sharma SD; Araujo FG; Remington JS
    J Immunol; 1984 Dec; 133(6):2818-20. PubMed ID: 6491277
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyclophosphamide on Toxoplasma gondii infection: reversal of the effect by passive immunization.
    Hafizi A; Modabber FZ
    Clin Exp Immunol; 1978 Sep; 33(3):389-94. PubMed ID: 737894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
    Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
    J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice.
    Dubey JP; Shen SK; Kwok OC; Frenkel JK
    J Parasitol; 1999 Aug; 85(4):657-62. PubMed ID: 10461945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice.
    Murray HW; Teitelbaum R; Hariprashad J
    J Infect Dis; 1993 May; 167(5):1173-7. PubMed ID: 8486951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-7 stimulates protective immunity in mice against the intracellular pathogen, Toxoplasma gondii.
    Kasper LH; Matsuura T; Khan IA
    J Immunol; 1995 Nov; 155(10):4798-804. PubMed ID: 7594482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of cats against shedding of Toxoplasma oocysts.
    Frenkel JK; Smith DD
    J Parasitol; 1982 Oct; 68(5):744-8. PubMed ID: 7131181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
    Khan IA; Casciotti L
    J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immune reconstitution on resistance to Brugia pahangi in congenitally athymic nude mice.
    Vickery AC; Vincent AL; Sodeman WA
    J Parasitol; 1983 Jun; 69(3):478-85. PubMed ID: 6605421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
    Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
    Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.